Eventum Orthopaedics

Eventum Orthopaedics

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $7M

Overview

Eventum Orthopaedics is a private, early-stage med-tech startup from Yorkshire, England, developing data-driven surgical tools for orthopaedics. Its flagship product, Quadsense, is an FDA 510(k)-cleared device that provides real-time intraoperative load data for the kneecap (patellofemoral joint) during knee replacement surgery, addressing a key source of post-operative dissatisfaction. The company is pre-revenue, having secured £1.4 million in funding, and is expanding its platform with a data analytics tool called Datasense. Eventum aims to leverage intraoperative data to improve surgical outcomes and reduce the significant economic burden of revision surgeries and patient dissatisfaction.

OrthopaedicsMusculoskeletal

Technology Platform

Intraoperative sensing and data analytics platform for real-time measurement of joint biomechanics, starting with patellofemoral load in knee arthroplasty.

Funding History

2
Total raised:$7M
Grant$2M
Seed$5M

Opportunities

The large and growing global TKA market, with rising procedure volumes and a high dissatisfaction rate, presents a direct need for Eventum's solution.
The company's data platform strategy could create recurring revenue streams and defensible intellectual property beyond a single device.
Expansion into hip arthroplasty and other joints offers significant market extension opportunities.

Risk Factors

Commercial adoption risk is high, requiring a shift in surgeon behavior in a market dominated by large, entrenched competitors.
The company is pre-revenue and will require significant additional capital to fund commercialization and R&D.
Long-term clinical validation is needed to definitively prove improved patient outcomes and cost savings.

Competitive Landscape

Eventum operates in the orthopaedic surgical device market, competing indirectly with major implant manufacturers (e.g., Stryker, Zimmer Biomet, Johnson & Johnson) who offer integrated digital surgery platforms. Its direct competition is limited as Quadsense is first-to-market with real-time patellofemoral load data, but it faces competition from other intraoperative sensing technologies and broader surgical navigation/robotic systems.